Observational studies are complementary to randomized controlled trials

Nephron - Clinical Practice

Volumn 114, Issue 3, 2010, Pages

  Grootendorst, Diana C ^a   Jager, Kitty J ^b   Zoccali, Carmine ^c   Dekker, Friedo W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

Author keywords

Chronic kidney disease; Observational studies; Randomized controlled trials; Treatment effect

Indexed keywords

CASE CONTROL STUDY; CASE STUDY; COHORT ANALYSIS; INTERMETHOD COMPARISON; MEDICAL LITERATURE; NEPHROLOGY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; THERAPY EFFECT;

EVIDENCE-BASED MEDICINE; NETHERLANDS; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 70849130941     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000262299     Document Type: Review

References (22)

1. Stel VS, Zoccali C, Dekker FW, Jager KJ: The randomized controlled trial. Nephron Clin Pract 2009; 113:c337-c342
2. Lazarides MK, Georgiadis GS, Antoniou GA, Staramos DN: A meta-analysis of dialysis access outcome in elderly patients. J Vasc Surg 2007; 45: 420-426
3. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266
4. Black N: Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996; 312: 1215-1218
5. Euser AM, Zoccali C, Jager KJ, Dekker FW: Cohort studies: prospective versus retrospective. Nephron Clin Pract 2009; 113: c214-c217
6. van Stralen KJ, Dekker FW, Zoccali C, Jager KJ: Case-control studies. Nephron Clin Pract 2009; 114:c1-c4
7. Christensen E: Methodology of superiority vs. equivalence trials and non-inferiority trials. J Hepatol 2007; 46: 947-954
8. Rothman KJ: Epidemiology. An Introduction. Oxford, Oxford University Press, 2002
9. Vandenbroucke JP: When are observational studies as credible as randomised trials? Lancet 2004; 363: 1728-1731
10. Kolff WJ: Lasker Clinical Medical Research Award. The artificial kidney and its effect on the development of other artificial organs. Nat Med 2002; 8: 1063-1065
11. Scribner BH, Caner JE, Buri R, Quinton W: The technique of continuous hemodialysis. Trans Am Soc Artif Intern Organs 1960; 6: 88-103
12. Kolesnyk I, Dekker FW, Noordzij M, le Cessie S, Struijk DG, Krediet RT: Impact of ACE inhibitors and AII receptor blockers on peritoneal membrane transport characteristics in long-term peritoneal dialysis patients. Perit Dial Int 2007; 27: 446-453
13. Wolf G, Neilson EG: Angiotensin II as a renal growth factor. J Am Soc Nephrol 1993; 3: 1531-1540
14. Duman S, Gunal AI, Sen S, Asci G, Ozkahya M, Terzioglu E, Akcicek F, Atabay G: Does enalapril prevent peritoneal fibrosis induced by hypertonic (3.86%) peritoneal dialysis solution? Perit Dial Int 2001; 21: 219-224
15. Smets YF, Westendorp RG, van der Pijl JW, de Charro FT, Ringers J, de Fijter JW, Lemkes HH: Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure. Lancet 1999; 353: 1915-1919
16. Landgraf R: Impact of pancreas transplantation on diabetic secondary complications and quality of life. Diabetologia 1996; 39: 1415-1424 (Pubitemid 26397345)
17. Luzi L: Pancreas transplantation and diabetic complications. N Engl J Med 1998; 339: 115-117
18. Robertson RP, Holohan TV, Genuth S: Therapeutic controversy: pancreas transplantation for type I diabetes. J Clin Endocrinol Metab 1998; 83: 1868-1874
19. Korevaar JC, Feith GW, Dekker FW, van Manen JG, Boeschoten EW, Bossuyt PM, Krediet RT: Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int 2003; 64: 2222-2228
20. Jager KJ, Stel VS, Wanner C, Zoccali C, Dekker FW: The valuable contribution of observational studies to nephrology. Kidney Int 2007; 72: 671-675
21. Chmielewski M, Carrero JJ, Nordfors L, Lindholm B, Stenvinkel P: Lipid disorders in chronic kidney disease: reverse epidemiology and therapeutic approach. J Nephrol 2008; 21: 635-644
22. Donnelly LA, Doney AS, Dannfald J, Whitley AL, Lang CC, Morris AD, Donnan PT, Palmer CN: A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study. Pharmacogenet Genomics 2008; 18: 1021-1026